– Observed encouraging complete response (CR) rates as of the February 1, 2024, data cutoff in previously untreated HR-MDS and TP53m AML patients; successfully bridged responding TP53m AML patients to hematopoietic cell transplantation –

Vincerx continued to progress Phase 1 dose-escalation studies for VIP943, a potentially best-in-class anti-CD123 antibody-drug conjugate (ADC), and VIP236, a first-in-class small molecule-drug conjugate (SMDC)

SANTA CLARA, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Today, AMD (NASDAQ: AMD) announced the following events for the financial community:

Q2’24 Revenue Increased 7% to $17.2M; Management to Host Conference Call Today at 5:00 p.m. ET

Live webcast on Thursday, May 16^th at 4:00 PM ET

114% year-over-year increase in net product sales
70% prescriber growth in Q1 2024 compared to Q4 2023
Growing sales metrics reaffirms company’s $14M net revenue guidance for 2024

Increased Scope in Puerto Rico Expands Opportunity to $75 million

RENO, Nev., May 14, 2024 (GLOBE NEWSWIRE) -- Dragonfly Energy Holdings Corp. (“Dragonfly Energy” or the “Company”) (Nasdaq: DFLI), maker of Battle Born Batteries^® and an industry leader in energy storage, today reported its financial and operational results for the first quarter ended March 31, 2024.

WOBURN, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Bridgeline Digital, Inc. (NASDAQ: BLIN), a global leader in AI-powered marketing technology, today announced financial results for its fiscal second quarter ended March 31, 2024.

First Quarter 2024
US$5.3 billion Total Payment Volume, up 49% year-over-year and 4% quarter-over-quarter
Revenue of US$184 million, up 34% year-over-year and down -2% quarter-over-quarter
129% Net Revenue Retention Rate
Gross Profit of US$63 million, up 2% year-over-year and down -10% quarter-over-quarter
Adjusted EBITDA of US$37 million, down -19% year-over-year and -25% quarter-over-quarter

VirTra Advances Preparations for V-XR Deliveries

Announced positive proof of concept data from Phase 1 clinical trial of ELVN-001 in CML, achieving an initial cumulative MMR rate of 44% (7/16) by 12 weeks in response-evaluable patients

Revenues Increased 23% to $25.4 Million, Driven by New and Expanding Customer Subscriptions, and Contributions from SafePointe

SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial results for the first quarter ended March 31, 2024.

SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced its financial results for the first quarter ended March 31, 2024, and provided highlights on its clinical programs. 

SAN JOSE, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Infinera Corporation (NASDAQ: INFN) today released preliminary financial results for its first quarter ended March 30, 2024. Although presented with numerical specificity, all amounts in this press release are preliminary and based on management’s current expectations as of the date of this press release. These results are subject to all aspects of the final quarterly review process and may change as a result of new information that arises, or new determinations that are made, in this process.

Conference Call on Wednesday, May 15, 2024, at 8:30 a.m. ET with Accompanying Investor Presentation

CLEARFIELD, Pa., May 14, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of CNB Financial Corporation (Nasdaq: CCNE) declared a quarterly cash dividend of $0.175 per share of common stock payable on June 14, 2024 to common stock shareholders of record as of May 31, 2024.

CALGARY, Alberta, May 14, 2024 (GLOBE NEWSWIRE) -- Total Energy Services Inc. (“Total Energy” or the “Company”) (TSX:TOT) announces that the following matters were voted upon at the Company’s annual meeting of Shareholders on May 14, 2024 (the “Meeting”). A total of 27,868,857 common shares, representing 69.7% of Total Energy’s issued and outstanding shares as at the Record Date for the Meeting, were represented in person or by proxy at the Meeting.